Reference : Adhesion therapeutique aux antiagregants chez le patient coronarien.
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/168409
Adhesion therapeutique aux antiagregants chez le patient coronarien.
French
[en] Adherence to antiplatelet therapy in patients with coronary artery disease
Legrand, D. [> >]
Legrand, Victor mailto [Université de Liège - ULiège > Département des sciences cliniques > Cardiologie >]
2010
Revue Médicale de Liège
65
5-6
304-10
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Aspirin/therapeutic use ; Coronary Artery Disease/drug therapy ; Humans ; Medication Adherence/statistics & numerical data ; Platelet Aggregation Inhibitors/therapeutic use ; Ticlopidine/analogs & derivatives/therapeutic use
[en] Clinical benefit of antiplatelet therapy is established for cardiovascular disease and percutaneous coronary intervention (PCI). Dual antiplatelet therapy is used to optimize platelet inhibition. However, cardiovascular events still occur. Aspirin/clopidogrel resistance and poor compliance are the main factors implied in recurrent events. Compliance to dual antiplatelet therapy is particularly relevant during the first 6 months following acute coronary syndromes and PCI. Furthermore, several studies have shown association between antiplatelet resistance and poor compliance. Additionally, late (1 month to 1 year) and very late (> 1 year) stent thromboses are intimately linked to interruption of antiplatelet treatment. In this article we review the latest data about compliance, resistance and recommendations regarding antiplatelet therapy.
http://hdl.handle.net/2268/168409

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
legrand d adhesion therapetique aux antiagregants chez coronarien.pdfPublisher postprint333.44 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.